ConductScience.org, home

Paper29248564

EL20, a potent antiarrhythmic compound, selectively inhibits calmodulin-deficient ryanodine receptor type 2.

Klipp RC and 7 others. Heart Rhythm, 2018. Cited by 29 papers, by iCite.

Cite this record

ConductScience Library. EL20, a potent antiarrhythmic compound, selectively inhibits calmodulin-deficient ryanodine receptor type 2. Papers, record 29248564. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29248564

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
EL20, a potent antiarrhythmic compound, selectively inhibits calmodulin-deficient ryanodine receptor type 2.
PubMed
Journal
Heart Rhythm
PubMed
Year
2018
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
29
iCite
Relative citation ratio, by iCite
1.15
iCite
Revised in PubMed
2025-01-03
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Klipp RCRobert C
2Li NNa
3Wang QQiongling
4Word TATarah A
5Sibrian-Vazquez MMartha
6Strongin RMRobert M
7Wehrens XHTXander H T
8Abramson JJJonathan J

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anti-Arrhythmia AgentsMajor topic
CalmodulinMajor topic
DNAMajor topic
MutationMajor topic
Myocytes, CardiacMajor topic
Ryanodine Receptor Calcium Release ChannelMajor topic
Tachycardia, VentricularMajor topic
Animals
Calcium
DNA Mutational Analysis
Disease Models, Animal
Mice
Mice, Mutant Strains
Sarcoplasmic Reticulum
Sheep
Polymorphic Catecholaminergic Ventricular Tachycardia

Source PubMed

Download CSV of topics

Grants6

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R42 HL114206NHLBI NIH HHSUnited StatesR42HL114206PubMed and NIHNIH RePORTER
R41 HL129570NHLBI NIH HHSUnited StatesR41HL129570PubMed and NIHNIH RePORTER
R01 HL136389NHLBI NIH HHSUnited StatesR01HL136389PubMed and NIHNIH RePORTER
R01 HL091947NHLBI NIH HHSUnited StatesR01HL091947PubMed and NIHNIH RePORTER
R01 HL089598NHLBI NIH HHSUnited StatesR01HL089598PubMed and NIHNIH RePORTER
R01 HL117641NHLBI NIH HHSUnited StatesR01HL117641PubMed and NIHNIH RePORTER

Download CSV of grants

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in29410362Tetracaine derivatives for catecholaminergic polymorphic ventricular tachycardia: New drugs for correction of diastolic Ca2+ leak?https://conductscience.org/library/papers/29410362

Source PubMed

Download CSV of comments and corrections

References32

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
112386154Absence of calsequestrin 2 causes severe forms of catecholaminergic polymorphic ventricular tachycardia.Circ Res2002https://conductscience.org/library/papers/12386154PubMed
212707260Molecular basis of calmodulin binding to cardiac muscle Ca(2+) release channel (ryanodine receptor).J Biol Chem2003https://conductscience.org/library/papers/12707260PubMed
322158709Inhibition of CaMKII phosphorylation of RyR2 prevents induction of atrial fibrillation in FKBP12.6 knockout mice.Circ Res2012https://conductscience.org/library/papers/22158709PubMed
425920678Essential Role of Calmodulin in RyR Inhibition by Dantrolene.Mol Pharmacol2015https://conductscience.org/library/papers/25920678PubMed
521616285Flecainide therapy reduces exercise-induced ventricular arrhythmias in patients with catecholaminergic polymorphic ventricular tachycardia.J Am Coll Cardiol2011https://conductscience.org/library/papers/21616285PubMed
620226167Defective calmodulin binding to the cardiac ryanodine receptor plays a key role in CPVT-associated channel dysfunction.Biochem Biophys Res Commun2010https://conductscience.org/library/papers/20226167PubMed
724186966Cardiac myocyte Z-line calmodulin is mainly RyR2-bound, and reduction is arrhythmogenic and occurs in heart failure.Circ Res2014https://conductscience.org/library/papers/24186966PubMed
88175760Reconstitution of the skeletal muscle ryanodine receptor-Ca2+ release channel protein complex into proteoliposomes.J Biol Chem1994https://conductscience.org/library/papers/8175760PubMed
917431507Early cardiac hypertrophy in mice with impaired calmodulin regulation of cardiac muscle Ca release channel.J Clin Invest2007https://conductscience.org/library/papers/17431507PubMed
1014747315Mechanism of calmodulin inhibition of cardiac sarcoplasmic reticulum Ca2+ release channel (ryanodine receptor).Biophys J2004https://conductscience.org/library/papers/14747315PubMed
1112919952Ryanodine receptor mutations associated with stress-induced ventricular tachycardia mediate increased calcium release in stimulated cardiomyocytes.Circ Res2003https://conductscience.org/library/papers/12919952PubMed
1212069756Regulation of ryanodine receptors via macromolecular complexes: a novel role for leucine/isoleucine zippers.Trends Cardiovasc Med2002https://conductscience.org/library/papers/12069756PubMed
1312445877The cardiac ryanodine receptor (calcium release channel): emerging role in heart failure and arrhythmia pathogenesis.Cardiovasc Res2002https://conductscience.org/library/papers/12445877PubMed
141621949Bound and determined: a computer program for making buffers of defined ion concentrations.Anal Biochem1992https://conductscience.org/library/papers/1621949PubMed
1520388639Dissociation of calmodulin from cardiac ryanodine receptor causes aberrant Ca(2+) release in heart failure.Cardiovasc Res2010https://conductscience.org/library/papers/20388639PubMed
1627318036CaMKII-dependent phosphorylation of RyR2 promotes targetable pathological RyR2 conformational shift.J Mol Cell Cardiol2016https://conductscience.org/library/papers/27318036PubMed
1717588328Ryanodine receptors as pharmacological targets for heart disease.Acta Pharmacol Sin2007https://conductscience.org/library/papers/17588328PubMed
1816873551Mice with the R176Q cardiac ryanodine receptor mutation exhibit catecholamine-induced ventricular tachycardia and cardiomyopathy.Proc Natl Acad Sci U S A2006https://conductscience.org/library/papers/16873551PubMed
1927838126Treatment of catecholaminergic polymorphic ventricular tachycardia in mice using novel RyR2-modifying drugs.Int J Cardiol2017https://conductscience.org/library/papers/27838126PubMed
2022067155FRET detection of calmodulin binding to the cardiac RyR2 calcium release channel.Biophys J2011https://conductscience.org/library/papers/22067155PubMed

See all 32 referencesDownload CSV of references

Cited by19

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 29 citations.

PMIDTitleJournalYearIn PapersSource
39835466Genetics, manifestations, and management of catecholaminergic polymorphic ventricular tachycardia.Curr Opin Cardiol2025https://conductscience.org/library/papers/39835466PubMed
38855953Development of Ryanodine Receptor (RyR) Inhibitors for Skeletal Muscle and Heart Diseases.Juntendo Iji Zasshi2023https://conductscience.org/library/papers/38855953PubMed
38542006Catecholaminergic Polymorphic Ventricular Tachycardia: Clinical Characteristics, Diagnostic Evaluation and Therapeutic Strategies.J Clin Med2024https://conductscience.org/library/papers/38542006PubMed
38205355Mind the Gap: Does Junctophilin 2 Gear the Coupled-Clock System in Pacemaker Cardiomyocytes?JACC Basic Transl Sci2023https://conductscience.org/library/papers/38205355PubMed
38205351Junctional Ectopic Tachycardia Caused by Junctophilin-2 Expression Silencing Is Selectively Sensitive to Ryanodine Receptor Blockade.JACC Basic Transl Sci2023https://conductscience.org/library/papers/38205351PubMed
37387319RYR2-ryanodinopathies: from calcium overload to calcium deficiency.Europace2023https://conductscience.org/library/papers/37387319PubMed
36706317Reduction in Junctophilin 2 Expression in Cardiac Nodal Tissue Results in Intracellular Calcium-Driven Increase in Nodal Cell Automaticity.Circ Arrhythm Electrophysiol2023https://conductscience.org/library/papers/36706317PubMed
36369981Repeatability of ventricular arrhythmia characteristics on the exercise-stress test in RYR2-mediated catecholaminergic polymorphic ventricular tachycardia.Europace2023https://conductscience.org/library/papers/36369981PubMed
35677449Structural Insight Into Ryanodine Receptor Channelopathies.Front Pharmacol2022https://conductscience.org/library/papers/35677449PubMed
35457253Therapeutic Approaches of Ryanodine Receptor-Associated Heart Diseases.Int J Mol Sci2022https://conductscience.org/library/papers/35457253PubMed
35426759Targeting calcium-mediated inter-organellar crosstalk in cardiac diseases.Expert Opin Ther Targets2022https://conductscience.org/library/papers/35426759PubMed
34110090Efficacy of RyR2 inhibitor EL20 in induced pluripotent stem cell-derived cardiomyocytes from a patient with catecholaminergic polymorphic ventricular tachycardia.J Cell Mol Med2021https://conductscience.org/library/papers/34110090PubMed
33399957Mechanisms underlying pathological Ca2+ handling in diseases of the heart.Pflugers Arch2021https://conductscience.org/library/papers/33399957PubMed
32832689Structural mechanism of two gain-of-function cardiac and skeletal RyR mutations at an equivalent site by cryo-EM.Sci Adv2020https://conductscience.org/library/papers/32832689PubMed
32678103Inherited cardiac arrhythmias.Nat Rev Dis Primers2020https://conductscience.org/library/papers/32678103PubMed
31869254Targeting pathological leak of ryanodine receptors: preclinical progress and the potential impact on treatments for cardiac arrhythmias and heart failure.Expert Opin Ther Targets2020https://conductscience.org/library/papers/31869254PubMed
30904562Channelopathies - An update 2018.Indian Pacing Electrophysiol J2019https://conductscience.org/library/papers/30904562PubMed
30374311Arrhythmogenic Mechanisms in Heart Failure: Linking β-Adrenergic Stimulation, Stretch, and Calcium.Front Physiol2018https://conductscience.org/library/papers/30374311PubMed
29410362Tetracaine derivatives for catecholaminergic polymorphic ventricular tachycardia: New drugs for correction of diastolic Ca2+ leak?Heart Rhythm2018https://conductscience.org/library/papers/29410362PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
RYR26262PubTator's text mininghttps://conductscience.org/library/genes/6262

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/29248564

GET https://conductscience.org/api/papers/v1/29248564/references?page=2